GcMAF (Gc protein-derived macrophage activating factor) is a protein that has been explored for its potential benefits in treating various conditions, including Lyme disease. Here are some of the reported benefits of GcMAF for Lyme disease: Immune System Support : GcMAF enhances the activity of macrophages, which are crucial cells in the immune system responsible for engulfing and destroying pathogens, including the bacteria that cause Lyme disease. Reduction of Inflammation : studies suggest that GcMAF helps reduce inflammation, which is a common symptom in Lyme disease patients. Improvement in Symptoms : Patients have reported improvements in symptoms such as fatigue, joint pain, A few herbal tinctures and supplements were added to the protocol. Light therapy and Ozone I.V also added to the protocol. 

During the treatment, the patient reported significant improvements in energy levels and a reduction in joint pain and neurological symptoms. Follow-up tests showed a significant decrease in inflammatory markers, suggesting that GcMAF was effective in modulating the immune response and reducing inflammation. 

Conclusion : 

At the end of the 3 months treatment period : the patient experienced a substantial 95% improvement in quality of life, with most symptoms either resolved or significantly diminished. The patient continues to follow diet and lifestyle changes with just a few supplements daily. This case highlights the potential of GcMAF as a complementary therapy for chronic Lyme disease, particularly for patients who do not respond adequately to standard treatments.